Earnings Preview: Regeneron Pharmaceuticals

Regeneron Pharmaceuticals REGN is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement.

Analysts estimate that Regeneron Pharmaceuticals will report an earnings per share (EPS) of $10.04.

Regeneron Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $5.61, which was followed by a 0.0% drop in the share price the next day.

Here's a look at Regeneron Pharmaceuticals's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 18.11 9.49 17.69 9.03
EPS Actual 23.72 15.37 25.80 9.89
Price Change % 0.37% -5.57% 1.39% -0.39%

eps graph

Stock Performance

Shares of Regeneron Pharmaceuticals were trading at $652.02 as of May 02. Over the last 52-week period, shares are up 34.97%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Regeneron Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!